Total Payments
$12,766
2024 Payments
$1,904
Companies
54
Transactions
920
Medicare Patients
7,690
Medicare Billing
$480,503
Payment Breakdown by Category
Food & Beverage$12,660 (99.2%)
Education$105.52 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,660 | 907 | 99.2% |
| Education | $105.52 | 13 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,134 | 162 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,745 | 84 | $0 (2024) |
| PFIZER INC. | $1,306 | 124 | $0 (2024) |
| Amgen Inc. | $864.50 | 59 | $0 (2024) |
| ABBVIE INC. | $752.36 | 47 | $0 (2024) |
| Lilly USA, LLC | $726.54 | 52 | $0 (2024) |
| GlaxoSmithKline, LLC. | $580.14 | 41 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $550.73 | 39 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $536.24 | 48 | $0 (2024) |
| Abbott Laboratories | $455.85 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,904 | 113 | AstraZeneca Pharmaceuticals LP ($261.98) |
| 2023 | $1,563 | 93 | ABBVIE INC. ($225.22) |
| 2022 | $1,568 | 86 | Novo Nordisk Inc ($411.72) |
| 2021 | $1,147 | 79 | AstraZeneca Pharmaceuticals LP ($245.60) |
| 2020 | $1,008 | 73 | Novo Nordisk Inc ($278.24) |
| 2019 | $1,429 | 117 | PFIZER INC. ($269.61) |
| 2018 | $1,400 | 115 | PFIZER INC. ($374.72) |
| 2017 | $2,745 | 244 | Novo Nordisk Inc ($392.17) |
All Payment Transactions
920 individual payment records from CMS Open Payments — Page 37 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/31/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $10.28 | General |
| Category: RESPIRATORY | ||||||
| 01/30/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/27/2017 | Lilly USA, LLC | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Diabetes | ||||||
| 01/26/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Diabetes | ||||||
| 01/25/2017 | PFIZER INC. | VIAGRA (Drug), ELIQUIS, CHANTIX | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 01/25/2017 | PFIZER INC. | CHANTIX (Drug), LYRICA | Food and Beverage | In-kind items and services | $0.35 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/20/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/20/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $2.66 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/18/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: DIABETES | ||||||
| 01/17/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: DIABETES | ||||||
| 01/13/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Diabetes | ||||||
| 01/13/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $1.67 | General |
| Category: Diabetes | ||||||
| 01/12/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: RESPIRATORY | ||||||
| 01/12/2017 | Allergan Inc. | VIIBRYD (Drug) | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug), BEVESPI AEROSPHERE, FARXIGA | Food and Beverage | In-kind items and services | $106.85 | General |
| Category: Respiratory | ||||||
| 01/09/2017 | Becton, Dickinson and Company | BD Nano (Device) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Diabetes Care | ||||||
| 01/06/2017 | Merck Sharp & Dohme Corporation | ASMANEX (Drug), BELSOMRA, DULERA | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: RESPIRATORY | ||||||
| 01/05/2017 | PFIZER INC. | VIAGRA (Drug), LYRICA | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 01/04/2017 | Lilly USA, LLC | HUMALOG (Drug), TRULICITY, BASAGLAR | Food and Beverage | In-kind items and services | $9.86 | General |
| Category: Diabetes | ||||||
| 01/03/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $9.94 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,723 | 2,796 | $496,876 | $107,832 |
| 2022 | 23 | 1,890 | 3,071 | $341,554 | $103,568 |
| 2021 | 25 | 2,312 | 3,452 | $341,944 | $156,588 |
| 2020 | 25 | 1,765 | 2,931 | $280,168 | $112,514 |
Total Patients
7,690
Total Services
12,250
Medicare Billing
$480,503
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 99 | 100 | $4,700 | $4,607 | 98.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 49 | 52 | $21,247 | $4,597 | 21.6% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2022 | 31 | 450 | $10,128 | $3,432 | 33.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 108 | 109 | $5,264 | $3,117 | 59.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 68 | 75 | $9,948 | $3,052 | 30.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 125 | 125 | $3,875 | $2,290 | 59.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 34 | $8,010 | $1,910 | 23.9% |
| 85610 | Blood test, clotting time | Office | 2022 | 33 | 305 | $3,355 | $1,293 | 38.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 29 | 33 | $1,221 | $1,221 | 100.0% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 40 | 46 | $2,600 | $1,001 | 38.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 17 | 17 | $1,292 | $856.32 | 66.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 26 | 26 | $1,221 | $746.82 | 61.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 12 | 22 | $2,243 | $712.44 | 31.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 12 | 12 | $3,864 | $442.83 | 11.5% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2022 | 21 | 21 | $963.00 | $374.37 | 38.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 11 | 22 | $792.00 | $358.16 | 45.2% |
| 69209 | Removal of impacted ear wax by washing | Office | 2022 | 20 | 21 | $424.00 | $244.57 | 57.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 19 | 19 | $873.00 | $180.93 | 20.7% |
| 81002 | Urinalysis, manual test | Office | 2022 | 26 | 31 | $310.00 | $106.12 | 34.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 565 | 814 | $136,752 | $52,337 | 38.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 329 | 401 | $44,912 | $15,980 | 35.6% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 54 | 61 | $24,400 | $13,634 | 55.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 100 | 100 | $16,500 | $13,220 | 80.1% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 59 | 67 | $18,961 | $11,094 | 58.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 54 | 54 | $13,500 | $9,056 | 67.1% |
About Dr. Dann Fredrickson, MD
Dr. Dann Fredrickson, MD is a Internal Medicine healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215934203.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dann Fredrickson, MD has received a total of $12,766 in payments from pharmaceutical and medical device companies, with $1,904 received in 2024. These payments were reported across 920 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($12,660).
As a Medicare-enrolled provider, Fredrickson has provided services to 7,690 Medicare beneficiaries, totaling 12,250 services with total Medicare billing of $480,503. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Kansas City, MO
- Active Since 07/05/2005
- Last Updated 09/26/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1215934203
Products in Payments
- FARXIGA (Drug) $1,038
- Ozempic (Drug) $770.12
- VRAYLAR (Drug) $562.99
- Victoza (Drug) $561.51
- XARELTO (Drug) $413.37
- Rybelsus (Drug) $361.18
- EVENITY (Biological) $356.83
- BREZTRI (Drug) $354.00
- CHANTIX (Drug) $347.51
- JARDIANCE (Drug) $343.00
- Vascepa (Drug) $321.85
- FREESTYLE LIBRE 3 (Device) $295.33
- ELIQUIS (Drug) $262.88
- MOUNJARO (Drug) $240.89
- Movantik (Drug) $207.23
- ENTRESTO (Drug) $202.64
- LYRICA (Drug) $198.87
- NURTEC ODT (Drug) $192.98
- VIAGRA (Drug) $182.10
- Prolia (Biological) $180.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kansas City
James O'keefe, Md, MD
Internal Medicine — Payments: $834,178
Internal Medicine $834,178
Shadi Hamdeh, Md, MD
Internal Medicine — Payments: $623,244
Internal Medicine $623,244
Dr. Patrick Moriarty, M.d, M.D
Internal Medicine — Payments: $618,967
Internal Medicine $618,967
Gerald Mancuso, M.d, M.D
Internal Medicine — Payments: $615,894
Internal Medicine $615,894
Dr. Ryan Taylor, M.d, M.D
Internal Medicine — Payments: $512,094
Internal Medicine $512,094
Sanjaya Gupta, Md, MD
Internal Medicine — Payments: $325,155
Internal Medicine $325,155